Johnson & Johnson to Webcast Annual Meeting of Shareholders

NEW BRUNSWICK, N.J., March 27, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will webcast its Annual Meeting of Shareholders at 10 a.m. (Eastern Time) on Thursday, April 23, 2015, from the State Theatre in New Brunswick, N.J.

Investors and other interested parties may access the live audio webcast of the meeting by visiting the Company's website at www.jnj.com and clicking on the webcast icon.

A replay of presentations from the meeting will be made available a few hours after the live meeting concludes.  The webcast will remain available for replay for three months following the meeting.  The replay can be accessed by clicking on "Webcasts & Presentations" in the Investor Relations section of the Company's website.  Interested parties can also follow the meeting on Twitter using #JNJASM15.

About Johnson & Johnson 
Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,500 employees at more than 265 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-to-webcast-annual-meeting-of-shareholders-300056830.html

SOURCE Johnson & Johnson

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.